Skip to main content

Table 1 Site comparison

From: Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders

  Site 1 (Essen)
n = 99
Site 2 (Gummersbach)
n = 52
  Present (%) Lifetime (%) Present (%) Lifetime (%)
Gender     
   male 78 (78.8) - 36 (69.2) -
Age (Mean) 17.95 (SD = 1.84) - 16.75 (SD = 1.61) -
SUDa     
   Alcohol 36 (36.4) 44 (44.4) 13 (25.0) 14 (26.9)*
   Cannabis 80 (80.8) 86 (86.9) 38 (73.1) 42 (80.8)
   Amphetamine-like substances 22 (22.2) 28 (28.3) 5 (9.6) 6 (11.5)*
   Hallucinogensb 7 (7.1) 11 (11.1) 0 (0.0) 1 (1.9)*
   Cocaine 8 (8.1) 9 (9.1) 0 (0.0)* 1 (1.9)
   Opiates 10 (10.1) 10 (10.1) 1 (1.9) 1 (1.9)
   Inhalants 1 (1.0) 2 (2.0) 1 (1.9) 1 (1.9)
   Sedative 2 (2.0) 4 (4.0) 0 (0.0) 2 (3.8)
   Polysubstance 0 (0.0) 1 (1.0) 13 (25.0)*** 15 (28.8)***
Mood disorders 21 (21.2) 23 (23.2) 8 (15.4) 10 (19.2)
Anxiety disorders 17 (17.2) 21 (21.2) 17 (32.7)* 19 (36.5)*
Adjustment disorder 0 (0.0) 0 (0.0) 2 (3.8)* 2 (3.8)*
Somatoform disorders 8 (8.1) 14 (14.1) 6 (11.5) 8 (15.4)
ADHDc 3 (12.0) 8 (32.0) 3 (7.5) 5 (12.5)
Conduct disorderc 12 (48.0) 19 (76.0) 15 (37.5) 20 (50.0)*
Axis I disorder(s) d 36 (36.4) 41 (41.4) 25 (48.1) 28 (53.8)
  1. Note: a SUD = Substance use disorder: abuse or dependence according to DSM-IV-TR, without nicotine SUD. b including psychotropic mushrooms. c Subgroup, n = 65. d without CD and ADHD. * p < .05, ** p < .01, *** p < .00.